Europe Genome Editing Market by Application (Cell Line, Animal Genetic and Plant Genetic Engineering), by Technology (CRISPR, TALEN, ZFN, Antisense and Other Technologies), by End User (Biotechnological & Pharmaceutical Companies, Academic and Government Research Institutes and Contract Research Organizations), and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

Europe Genome Editing Market by Application (Cell Line, Animal Genetic and Plant Genetic Engineering), by Technology (CRISPR, TALEN, ZFN, Antisense and Other Technologies), by End User (Biotechnological & Pharmaceutical Companies, Academic and Government Research Institutes and Contract Research Organizations), and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

ID: 2790 | Pages: 140 | August 2017 | Region: Europe


The Europe Genome Editing Market was worth USD 0.68 billion in 2016 and estimated to be growing at a CAGR of 14.13%, to reach USD 1.32 billion by 2021. Genome editing is a way of making specific changes to the DNA of a cell or organism. By editing the genome of an organism, its characteristics can be changed. An approach commonly used in biological research is modifying the DNA of an organism and observing its impact. This is called reverse genetics and is what Genome Editing is based on.

Genome Editing uses a special type of enzyme called an engineered nuclease which cuts the genome in the desired place. The cut part will naturally be repaired by the cell which can be manipulated to make changes to the DNA in that location. The changes can be small wherein just a small function of that section of DNA is affected or can be complete removal of a section of DNA. It is also possible to insert a section of DNA into the genome as and when the need for it arises.

The key drivers of the Europe Genome Editing Market include the applications of DNA editing in therapeutics, the use of the technology in disease eradication and alteration of pathogen targets in the host. The ability of genome editing therapies to provide a noteworthy improvement to healthcare services. Other factors affecting the growth include improved efficacy and reduced side effects of disease treatment. Inspite of the multitude of uses, the market still gets hampered by factors such as the high costs associated with genome editing, more specifically the equipment used, and the ethical concerns regarding genome editing which has been brought up by several NGOS.

The Europe Genome Editing market is broadly classified into Cell Line, Animal Genetic and Plant Genetic Engineering in the basis of application, by technology into CRISPR, TALEN, ZFN, Antisense and Other Technologies and on the basis of end user into Biotechnological & Pharmaceutical Companies, Academic and Government Research Institutes and Contract Research Organizations. Based on geography, the Europe market is analysed under various regions namely Italy, Germany, UK, Spain and France. Europe has the second highest market share globally albeit with less than average growth rate. The highly developed stature of this region can be held responsible for the low CAGR of the region.

The Genome Editing market is highly competitive with a large number of players. Some of the major ones are Thermo Fisher Scientific, Merck KGAA, Horizon Discovery Group Plc, Genscript Biotech Corporation, Sangamo Biosciences, Integrated DNA Technologies, Lonza Group Ltd, New England Biolabs, Origene Technologies, and Transposagen Biopharmaceuticals.

  1. Introduction

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

  1. Research Methodology

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

  1. Overview

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemiology                             

  1. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

  1. Market Segmentation

                5.1 Application                 

                                5.1.1 Introduction           

                                5.1.2 Cell Line Engineering           

                                5.1.3 Animal Genetic Engineering            

                                5.1.4 Plant Genetic Engineering

                                5.1.5 Y-o-Y Growth Analysis, By Application         

                                5.1.6 Market Attractiveness Analysis, By Application       

                                5.1.7 Market Share Analysis, By Application        

                5.2 Technology                 

                                5.3.1 Introduction           

                                5.3.2 CRISPR      

                                5.3.3 TALEN       

                                5.3.4 ZFN            

                                5.3.5 Antisense

                                5.3.6 Other Technologies             

                                5.3.7 Y-o-Y Growth Analysis, By Technology        

                                5.3.8 Market Attractiveness Analysis, By Technology      

                                5.3.9 Market Share Analysis, By Technology        

                5.3 End User                      

                                5.2.1 Introduction           

                                5.2.2 Biotechnological & Pharmaceutical Companies       

                                5.2.3 Academic and Government Research Institutes     

                                5.2.4 Contract Research Organizations   

                                5.2.5 Y-o-Y Growth Analysis, By End User             

                                5.2.6 Market Attractiveness Analysis, By End User           

                                5.2.7 Market Share Analysis, By End User             

  1. Geographical Analysis

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Application

                                                6.1.3.3 By Technology

                                                6.1.3.4 By End User

                                6.1.4 Market Attractiveness Analysis      

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Application

                                                6.1.4.3 By Technology

                                                6.1.4.4 By End User

                                6.1.5 Market Share Analysis       

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Application

                                                6.1.5.3 By Technology

                                                6.1.5.4 By End User

                6.2 U.K                 

                6.3 Spain                             

                6.4 Germany                     

                6.5 Italy                               

                6.6 France                          

  1. Strategic Analysis

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five Analysis                             

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

  1. Market Leaders' Analysis

                8.1 Thermo Fisher Scientific                        

                                8.1.1 Overview 

                                8.1.2 Application Analysis            

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Merck KGAA                              

                8.3 Horizon Discovery Group Plc                               

                8.4 Genscript Biotech Corporation                           

                8.5 Sangamo Biosciences                             

                8.6 Integrated DNA Technologies                            

                8.7 Lonza Group Ltd                       

                8.8 New England Biolabs                              

                8.9 Origene Technologies                            

                8.10 Transposagen Biopharmaceuticals                 

  1. Competitive Landscape

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

  1. Market Outlook and Investment Opportunities

Appendix                                           

  1. a) List of Tables
  2. b) List of Figures
  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Europe Genome Editing Market Market By Application, From 2016-2021 ( USD Billion )
  2. Europe Cell Line Engineering Market By Region, From 2016-2021 ( USD Billion )
  3. Europe Animal Genetic Engineering Market By Region, From 2016-2021 ( USD Billion )
  4. Europe Plant Genetic Engineering Market By Region, From 2016-2021 ( USD Billion )
  5. Europe Genome Editing Market Market By Technology, From 2016-2021 ( USD Billion )
  6. Europe CRISPR Market By Region, From 2016-2021 ( USD Billion )
  7. Europe TALEN Market By Region, From 2016-2021 ( USD Billion )
  8. Europe ZFN Market By Region, From 2016-2021 ( USD Billion )
  9. Europe Antisense Market By Region, From 2016-2021 ( USD Billion )
  10. Europe Other Technologies Market By Region, From 2016-2021 ( USD Billion )
  11. Europe Genome Editing Market Market By End User, From 2016-2021 ( USD Billion )
  12. Europe Biotechnological & Pharmaceutical Companies Market By Region, From 2016-2021 ( USD Billion )
  13. Europe Academic and Government Research Institutes Market By Region, From 2016-2021 ( USD Billion )
  14. Europe Contract Research Organizations Market By Region, From 2016-2021 ( USD Billion )
  15. U.K. Genome Editing Market Market By Application, From 2016-2021 ( USD Billion )
  16. U.K. Genome Editing Market Market By Technology, From 2016-2021 ( USD Billion )
  17. U.K. Genome Editing Market Market By End User, From 2016-2021 ( USD Billion )
  18. Germany Genome Editing Market Market By Application, From 2016-2021 ( USD Billion )
  19. Germany Genome Editing Market Market By Technology, From 2016-2021 ( USD Billion )
  20. Germany Genome Editing Market Market By End User, From 2016-2021 ( USD Billion )
  21. France Genome Editing Market Market By Application, From 2016-2021 ( USD Billion )
  22. France Genome Editing Market Market By Technology, From 2016-2021 ( USD Billion )
  23. France Genome Editing Market Market By End User, From 2016-2021 ( USD Billion )
  24. Italy Genome Editing Market Market By Application, From 2016-2021 ( USD Billion )
  25. Italy Genome Editing Market Market By Technology, From 2016-2021 ( USD Billion )
  26. Italy Genome Editing Market Market By End User, From 2016-2021 ( USD Billion )
  27. Spain Genome Editing Market Market By Application, From 2016-2021 ( USD Billion )
  28. Spain Genome Editing Market Market By Technology, From 2016-2021 ( USD Billion )
  29. Spain Genome Editing Market Market By End User, From 2016-2021 ( USD Billion )
Middle East And Africa Rubella Vaccine Market By End User (Pediatric Rubella Vaccine, Adult Rubella Vaccine, And Traveler Rubella Vaccine), And Region -Industry Analysis, Size, Share, Growth, Trends, And Forecasts (...
Latin America Rubella Vaccine Market By End User (Pediatric Rubella Vaccine, Adult Rubella Vaccine, And Traveler Rubella Vaccine), And Region -Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2017 To 2...
Asia Pacific Rubella Vaccine Market By End User (Pediatric Rubella Vaccine, Adult Rubella Vaccine, And Traveler Rubella Vaccine), And Region -Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2017 To 20...
Europe Rubella Vaccine Market By End User (Pediatric Rubella Vaccine, Adult Rubella Vaccine, And Traveler Rubella Vaccine), And Region -Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2017 To 2022)...
North America Rubella Vaccine Market By End User (Pediatric Rubella Vaccine, Adult Rubella Vaccine, And Traveler Rubella Vaccine), And Region -Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2017 To 2...
Rubella Vaccine Market By End User (Pediatric Rubella Vaccine, Adult Rubella Vaccine, And Traveler Rubella Vaccine), And Region -Global Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2017 To 2022)...
Middle-East And Africa Zika Virus Vaccines Market By Type (Therapeutic Vaccines, Preventive Vaccines), End-user (Hospitals, Clinics, Research Institutes, Others) And By Region - Industry Analysis, Size, Share, Growt...
Latin America Zika Virus Vaccines Market By Type (Therapeutic Vaccines, Preventive Vaccines), End-user (Hospitals, Clinics, Research Institutes, Others) And By Region - Industry Analysis, Size, Share, Growth, Trends...
Asia-Pacific Zika Virus Vaccines Market By Type (Therapeutic Vaccines, Preventive Vaccines), End-user (Hospitals, Clinics, Research Institutes, Others) And By Region - Industry Analysis, Size, Share, Growth, Trends,...
Europe Zika Virus Vaccines Market By Type (Therapeutic Vaccines, Preventive Vaccines), End-user (Hospitals, Clinics, Research Institutes, Others) And By Region - Industry Analysis, Size, Share, Growth, Trends, And F...
North America Zika Virus Vaccines Market By Type (Therapeutic Vaccines, Preventive Vaccines), End-user (Hospitals, Clinics, Research Institutes, Others) And By Region - Industry Analysis, Size, Share, Growth, Trends...
Zika Virus Vaccines Market By Type (Therapeutic Vaccines, Preventive Vaccines), End-user (Hospitals, Clinics, Research Institutes, Others) And By Region - Global Industry Analysis, Size, Share, Growth, Trends, And ...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2018 Market Data Forecast
All Rights Reserved.